Entero Healthcare Solutions opened higher at ₹1,646.00, compared with its previous close of ₹1,644.10. During today's session, the stock has traded between ₹1,591.20 and ₹1,661.10, with an average traded price of ₹1,610.66. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 3 years ago in Entero Healthcare Solutions is now worth
₹ 14,042.00
giving a profit of
₹ 4,042.00 (40.42%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-29.90 (-1.82%)
Day High
₹1,661.10
Day Low
₹1,591.20
Day Open
₹1,646.00
Prev Close
₹1,644.10
Volume
1,26,001
Value Traded
₹20.29 Cr
1W Return
-4.88%
1M Return
-11.08%
3M Return
33.31%
6M Return
34.83%
1Y Return
43.74%
Market Cap (₹ Cr.)
7,025
PE Ratio
42.70
PB Ratio
4.26
Dividend Yield
-
ROE
8.32%
ROCE
11.61%
Book Value (₹)
386.51
Face Value (₹)
10.00
EPS (TTM)
8.77
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-4.88%
6 Week
-
1 Month
-11.08%
3 Month
33.31%
9 Month
31.33%
Entero Healthcare Solutions to host virtual analyst call on September 29
Entero Healthcare Solutions Ltd scheduled a virtual analyst call for September 29, 2026. The meeting begins at 2:00 pm and is organized by Arihant Capital Markets Ltd. Discussions will be limited to publicly available information with no UPSI disclosure.
21 days agoPrasad Uno Family Trust sells 2.13m Entero Healthcare shares
Prasad Uno Family Trust sold 21.30 lakh shares in Entero Healthcare Solutions. Sale executed via bulk deal (7.40 lakh shares) and block deal (13.90 lakh shares). Post-sale, the trust's holding reduced from 7.94% to 3.05% of total share capital. Transactions occurred on September 17 and September 18, 2026.
21 days agoEntero Healthcare subsidiary penalised ₹12.9 lakh for GST E-Invoice lapse
Entero Healthcare subsidiary ACE Cardiopathy penalised ₹12,91,728 by UP GST Authority. Penalty levied for non-generation of E-Invoice; order received on September 11, 2026. Amount paid under protest to secure vehicle release and avoid demurrage losses. Company states impact is not material to consolidated financial position. Subsidiary plans to pursue recovery/refund through available GST law remedies.
1mo agoPrasad Uno Family Trust acquires 2.5% stake in Entero Healthcare via block deal
Prasad Uno Family Trust acquired 10,88,500 shares (2.50%) via block deal on August 24, 2026. Voting stake rose from 4.31% to 6.93% of total share capital. Encumbered shares dropped sharply from 6.13% to 1.01% of total capital. Filing made under SEBI SAST Regulations Regulation 29(2) on August 26, 2026.
1mo agoEntero Healthcare Solutions hosts investor conference on Sep 2
Entero Healthcare Solutions holds investor conference on September 2, 2026. Event organized by Elara Capital in physical mode at Mumbai. Officials to engage in 1x1 and group meetings starting 3:00 pm. Discussions limited to publicly available information only.
1mo agoEntero Healthcare Solutions sees Rajesh Dalal step down as independent director
Rajesh Shashikant Dalal ceases as Independent Director on August 24, 2026. Departure follows completion of his tenure at Entero Healthcare Solutions. He also steps down from chair roles in nomination and stakeholders committees. Disclosure made under Regulation 30 of SEBI Listing Regulations.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹617.00 | -1.69% | ₹7,412.46 | 35.77 | -21.32% | |
| ₹83.75 | +0.90% | ₹163.55 | 32.42 | +102.05% |
An investment of ₹10,000 made 3 years ago in Entero Healthcare Solutions is now worth
₹ 14,042.00
giving a profit of
₹ 4,042.00 (40.42%)
Note: Past profits do not guarantee future returns.
